These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27110714)

  • 1. Correction for Inhibition Leads to an Allosteric Co-Agonist Model for Pentobarbital Modulation and Activation of α1β3γ2L GABAA Receptors.
    Ziemba AM; Forman SA
    PLoS One; 2016; 11(4):e0154031. PubMed ID: 27110714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study.
    Pistis M; Belelli D; Peters JA; Lambert JJ
    Br J Pharmacol; 1997 Dec; 122(8):1707-19. PubMed ID: 9422818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monod-Wyman-Changeux Allosteric Shift Analysis in Mutant
    Szabo A; Nourmahnad A; Halpin E; Forman SA
    Mol Pharmacol; 2019 Apr; 95(4):408-417. PubMed ID: 30696720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An allosteric coagonist model for propofol effects on α1β2γ2L γ-aminobutyric acid type A receptors.
    Ruesch D; Neumann E; Wulf H; Forman SA
    Anesthesiology; 2012 Jan; 116(1):47-55. PubMed ID: 22104494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State-dependent etomidate occupancy of its allosteric agonist sites measured in a cysteine-substituted GABAA receptor.
    Stewart DS; Hotta M; Desai R; Forman SA
    Mol Pharmacol; 2013 Jun; 83(6):1200-8. PubMed ID: 23525330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monod-Wyman-Changeux allosteric mechanisms of action and the pharmacology of etomidate.
    Forman SA
    Curr Opin Anaesthesiol; 2012 Aug; 25(4):411-8. PubMed ID: 22614249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of structures within GABAA receptor alpha subunits that regulate the agonist action of pentobarbital.
    Drafts BC; Fisher JL
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1094-101. PubMed ID: 16728592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gating allosterism at a single class of etomidate sites on alpha1beta2gamma2L GABA A receptors accounts for both direct activation and agonist modulation.
    Rüsch D; Zhong H; Forman SA
    J Biol Chem; 2004 May; 279(20):20982-92. PubMed ID: 15016806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional sites involved in modulation of the GABAA receptor channel by the intravenous anesthetics propofol, etomidate and pentobarbital.
    Maldifassi MC; Baur R; Sigel E
    Neuropharmacology; 2016 Jun; 105():207-214. PubMed ID: 26767954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentobarbital differentially modulates alpha1beta3delta and alpha1beta3gamma2L GABAA receptor currents.
    Feng HJ; Bianchi MT; Macdonald RL
    Mol Pharmacol; 2004 Oct; 66(4):988-1003. PubMed ID: 15247320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-amino butyric acid type A receptor mutations at beta2N265 alter etomidate efficacy while preserving basal and agonist-dependent activity.
    Desai R; Ruesch D; Forman SA
    Anesthesiology; 2009 Oct; 111(4):774-84. PubMed ID: 19741491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA Type A Receptor Activation in the Allosteric Coagonist Model Framework: Relationship between EC
    Akk G; Shin DJ; Germann AL; Steinbach JH
    Mol Pharmacol; 2018 Feb; 93(2):90-100. PubMed ID: 29150461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tryptophan mutations at azi-etomidate photo-incorporation sites on alpha1 or beta2 subunits enhance GABAA receptor gating and reduce etomidate modulation.
    Stewart D; Desai R; Cheng Q; Liu A; Forman SA
    Mol Pharmacol; 2008 Dec; 74(6):1687-95. PubMed ID: 18805938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of propofol and pentobarbital on ligand binding to GABAA receptors suggest a similar mechanism of action.
    Davies M; Thuynsma RP; Dunn SM
    Can J Physiol Pharmacol; 1998 Jan; 76(1):46-52. PubMed ID: 9564548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of GABA
    Shin DJ; Germann AL; Covey DF; Steinbach JH; Akk G
    Mol Pharmacol; 2019 Jan; 95(1):70-81. PubMed ID: 30337372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel properties of homomeric beta 1 gamma-aminobutyric acid type A receptors: actions of the anesthetics propofol and pentobarbital.
    Sanna E; Garau F; Harris RA
    Mol Pharmacol; 1995 Feb; 47(2):213-7. PubMed ID: 7870027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional properties and mechanism of action of PPTQ, an allosteric agonist and low nanomolar positive allosteric modulator at GABA
    Madjroh N; Olander ER; Bundgaard C; Söderhielm PC; Jensen AA
    Biochem Pharmacol; 2018 Jan; 147():153-169. PubMed ID: 29155148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Constitutive Activity Accounts for the Combination of Enhanced Direct Activation and Reduced Potentiation in Mutated GABA
    Germann AL; Shin DJ; Kuhrau CR; Johnson AD; Evers AS; Akk G
    Mol Pharmacol; 2018 May; 93(5):468-476. PubMed ID: 29439087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of alpha6-containing GABAA receptors by pentobarbital occurs through a different mechanism than activation by GABA.
    Fisher MT; Fisher JL
    Neurosci Lett; 2010 Mar; 471(3):195-9. PubMed ID: 20109529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes.
    Whittemore ER; Yang W; Drewe JA; Woodward RM
    Mol Pharmacol; 1996 Nov; 50(5):1364-75. PubMed ID: 8913369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.